Researchers Observe Sustained Remission in Monkeys with HIV-Like Virus
- Details
- Category: Search for a Cure
- Published on Sunday, 16 October 2016 00:00
- Written by Liz Highleyman
Researchers have induced sustained remission of simian immune deficiency virus (SIV), a relative of HIV, in macaque monkeys treated with antiretroviral therapy (ART) and an antibody-based therapy used to treat inflammatory bowel disease, according to a report in the October 14 edition of Science. The monkeys not only had undetectable viral load for up to nearly 2 years after stopping treatment, but they also showed replenishment of key immune cells in the gut.
Resources for People with HIV and Hepatitis in Disaster Areas
- Details
- Category: HIV Treatment
- Published on Wednesday, 05 October 2016 00:00
- Written by HIVandHepatitis.com
During and after disasters such as Hurricane Matthew, people with medical conditions including HIV and viral hepatitis will be among those displaced and requiring emergency care. Government agencies offer resources for people with these and other chronic conditions, healthcare providers, and others who provide emergency and disaster-related services.
Nationwide PrEP Search Engine Debuts at U.S. Conference on AIDS
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Friday, 16 September 2016 00:00
- Written by Emory University
Emory University and partners have developed a new web-based directory of PrEP providers across the U.S., launching the project at the U.S. Conference on AIDS taking place this week in Hollywood, Florida. The search engine can be used to help people find physicians or clinics in their area that will prescribe Truvada (tenofovir/emtricitabine) for HIV prevention.
Truvada PrEP Linked to Rare Case of Serious Kidney Disorder
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Wednesday, 05 October 2016 00:00
- Written by Liz Highleyman
Researchers in Southern California have identified the first known case of Fanconi syndrome, a type of serious kidney dysfunction, in an otherwise healthy man taking Truvada (tenofovir/emtricitabine) for pre-exposure prophylaxis (PrEP), according to a poster presented at the 18th International Workshop on Co-morbidities and Adverse Drug Reactions in HIV last month in New York City. This case underlines the importance of regular kidney function monitoring while on PrEP.
AIDS 2016: Vaginal Ring for HIV Prevention is Effective and Acceptable
- Details
- Category: HIV Prevention
- Published on Thursday, 08 September 2016 00:00
- Written by Roger Pebody
An updated adherence analysis from the ASPIRE study indicates that consistent users of a vaginal ring containing dapivirine experienced 65% fewer HIV infections, according to a presentation at the recent 21st International AIDS Conference (AIDS 2016) in Durban. Moreover, African women who took part in the study told researchers that they liked the product, found it easy to use, and preferred it to possible alternatives such as tablets or vaginal gels.
Media Reports of a British HIV Cure Breakthrough Are Premature
- Details
- Category: Search for a Cure
- Published on Monday, 03 October 2016 00:00
- Written by Keith Alcorn
The Sunday Times yesterday reported that HIV had become undetectable in the blood of one man taking part in the RIVER study, a trial of an intensive treatment regimen designed to test whether it is possible to reduce levels of HIV-infected cells in the bodies of people recently infected with HIV. The Sunday Times reported that British scientists are on the "brink of an HIV cure." But in fact, the study is still in its early stages, participants are still on antiretroviral treatment, and it will not be able to describe participants as "cured" until extensive follow-up has taken place.
AIDS 2016: Realism Needed About the Benefits and Risks of Taking Part in HIV Cure Research
- Details
- Category: Search for a Cure
- Published on Thursday, 08 September 2016 00:00
- Written by Roger Pebody
A significant proportion of people living with HIV would be willing to take part in a study towards a cure for HIV, according to research presented at the recent 21st International AIDS Conference (AIDS 2016) in Durban. However, some potential participants may not fully understand that taking part in an early-phase study is highly unlikely to afford any personal clinical benefit, but might have the potential to cause harm.
September 27 Is National Gay Men's HIV/AIDS Awareness Day
- Details
- Category: Gay & Bisexual Men/MSM
- Published on Thursday, 22 September 2016 00:00
- Written by HIVandHepatitis.com
Tuesday, September 27, is National Gay Men's HIV/AIDS Awareness Day (NGMHAAD), a day of action to call attention to the disproportionate effect of the epidemic on gay, bisexual, and other men who have sex with men.
AIDS 2016: HIV Will Only Be Cured with Combined Approaches, Conference Delegates Hear
- Details
- Category: Search for a Cure
- Published on Thursday, 08 September 2016 00:00
- Written by Gus Cairns
Curing people of HIV infection will have to involve combinations of drugs and approaches, just as HIV treatment does, delegates heard at the Towards an HIV Cure workshop held in advance of the recent 21st International AIDS Conference (AIDS 2016) in Durban. The reason is the same, too: HIV can easily develop resistance to single agents, even ones as sophisticated as broadly neutralizing antibodies and gene-editing enzymes.
AIDS 2016: How Can Clinical Services Engage Men Who Have Sex With Men in Africa?
- Details
- Category: HIV Prevention
- Published on Tuesday, 20 September 2016 00:00
- Written by Roger Pebody
Men who have sex with men (MSM) living in African countries have an extremely high burden of HIV, Stefan Baral of Johns Hopkins University reminded delegates at the recent 21st International AIDS Conference (AIDS 2016) in Durban. But in situations often marked by widespread social disapproval of homosexual behavior, health services for MSM are few and far between.
AIDS 2016: Neglect of Infectious Disease in Prisons Highlighted at Conference
- Details
- Category: HIV/AIDS Epidemiology & Mortality
- Published on Wednesday, 07 September 2016 00:00
- Written by Theo Smart
A special issue of The Lancet was published to coincide with the recent 21st International AIDS Conference in Durban, containing a comprehensive seriesof reviews on the burden of HIV, hepatitis B, hepatitis C, and tuberculosis (TB) among prisoners worldwide.
AIDS 2016: NYC Clinic Outlines How to Improve PrEP Uptake by Transgender People
- Details
- Category: HIV Prevention
- Published on Tuesday, 20 September 2016 00:00
- Written by Roger Pebody
Dedicated efforts are needed to engage transgender men and women with clinical services and to encourage them to use pre-exposure prophylaxis (PrEP), Asa Radix from the Callen-Lorde Community Health Center in New York said during a presentation at the recent 21st International AIDS Conference (AIDS 2016) in Durban.
AIDS 2016: PrEP Study Achieves High Engagement and Adherence Among Black Gay Men
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Friday, 02 September 2016 00:00
- Written by Gus Cairns
What was described at the 21st International AIDS Conference (AIDS 2016) as the first PrEP trial devised and run by black gay men has shown that high levels of pre-exposure prophylaxis (PrEP) use, retention, and adherence can be achieved in a demonstration project if recruitment and support structures are tailored to the needs of black men who have sex with men.
Donors Pledge $13 Billion to Replenish Global Fund
- Details
- Category: Global Access
- Published on Tuesday, 20 September 2016 00:00
- Written by HIVandHepatitis.com
International donors committed to provide $12.9 billion over 3 years for the Global Fund to Fight AIDS, TB and Malaria at the fund's fifth replenishment conference, held last week in Montreal. "This replenishment is an enormous contribution to our collective ambition of ending AIDS," said UNAIDS executive director Michel Sidibé.
FDA Taking Public Comment on Potential Changes to Gay Blood Donation Policy
- Details
- Category: HIV Policy & Advocacy
- Published on Friday, 02 September 2016 00:00
- Written by Liz Highleyman
Through late November the U.S. Food and Drug Administration (FDA) is currently accepting public comments, supported by scientific evidence, as it considers changes to its policy restricting blood donations by gay and bisexual men. Instead of the current 1-year waiting period after a man has sex with another man, the agency is considering a more individualized policy that focuses on risk behavior rather than sexual orientation or self-identification.
September 18 is National HIV/AIDS and Aging Awareness Day
- Details
- Category: HIV & Aging
- Published on Friday, 16 September 2016 00:00
- Written by HIVandHepatitis.com
Sunday, September 18, is the annual observance of National HIV/AIDS and Aging Awareness Day (NHAAAD), an opportunity to focus on the HIV prevention, testing, care, and treatment for the aging population, as well as the health and well-being of the growing population of older people living with HIV.
AIDS 2016: Earlier HIV Treatment Is Not Over-burdening Health Services
- Details
- Category: Global Access
- Published on Thursday, 01 September 2016 00:00
- Written by Keith Alcorn
Earlier antiretroviral treatment initiation is not overwhelming rural health services in South Africa, but changes in treatment eligibility criteria alone may not be enough to increase the number of people on treatment substantially, and more investment will be needed in testing and linkage to care to reach treatment coverage goals, research presented at the recent 21st International AIDS Conference (AIDS 2016) shows.
Sweden Becomes First Country to Achieve UNAIDS 90-90-90 Targets
- Details
- Category: Cascade of Care
- Published on Friday, 16 September 2016 00:00
- Written by Michael Carter
Sweden has become the first country to achieve the UNAIDS/World Health Organization (WHO) 90-90-90 targets, research published in the August 18 advance edition of HIV Medicine shows. At the end of 2015, 90% of HIV cases in Sweden were diagnosed, 99.8% of people were linked to care, and 95% of people taking antiretroviral therapy for at least 6 months had a viral load below 50 copies/mL.
San Francisco Annual Report Shows New Low in HIV Infections But Disparities Remain
- Details
- Category: HIV/AIDS Epidemiology & Mortality
- Published on Thursday, 01 September 2016 00:00
- Written by Liz Highleyman
On September 1, the San Francisco Department of Public Health released its HIV Epidemiology Annual Report 2015, showing that the number of newly diagnosed HIV infections has continued to fall and people with HIV are being linked to care and achieving viral suppression more quickly. But some notable disparities remain, with African-American men and women not benefitting as much as the population as a whole.
USCA 2016: U.S. Conference on AIDS Discusses HIV Prevention and Access to Care
- Details
- Category: HIV Treatment
- Published on Friday, 16 September 2016 00:00
- Written by HIVandHepatitis.com
The U.S. Conference on AIDS (USCA 201c), sponsored by the National Minority AIDS Council,is taking place this week, September 15-18, in Hollywood, Florida. The largest U.S. conference focused on the community-based response to HIV/AIDS, USCA brings together researchers, front-line providers, community organizations, government policymakers, and people living with HIV and their advocates to discuss how to improve access to HIV prevention, care, and treatment.
AIDS 2016: Managing Non-Communicable Diseases Among People Living with HIV
- Details
- Category: HIV-Related Conditions
- Published on Thursday, 01 September 2016 00:00
- Written by Theo Smart
Speakers at the recent 21st International AIDS Conference in Durban addressed non-communicable diseases (NCDs) -- including cardiovascular diseases, diabetes, cancers, and other illnesses -- which have become more common complications for people with HIV who are living longer on antiretroviral therapy (ART). NCDs represent a significant challenge in low- and middle-income countries, where the burden of these illnesses has been reaching epidemic proportions, but where health systems have traditionally focused on providing episodic rather than chronic care.
Web Design and Development by